| Justin Matthew Lux, PHARMD | |
|
1700 Geary St Se, Albany, OR 97322-6842 | |
| (541) 812-5544 | |
| (541) 812-5545 |
| Full Name | Justin Matthew Lux |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 1700 Geary St Se, Albany, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063877454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | RPH-0013708 (Oregon) | Primary |
| 183500000X | Pharmacist | RPH-0013708 (Oregon) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Justin Matthew Lux, PHARMD 1700 Geary St Se, Albany, OR 97322-6842 Ph: (541) 812-5544 | Justin Matthew Lux, PHARMD 1700 Geary St Se, Albany, OR 97322-6842 Ph: (541) 812-5544 |
News Archive
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.
People infected with SARS-CoV-2, the virus that causes COVID-19, are known to shed it in their stool, even if they aren't experiencing any symptoms.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced favorable response and safety indications from a group of patients with advanced solid tumors (principally soft tissue sarcomas) in the Company's ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.
Several SARS-CoV-2 variants have emerged, posing a renewed threat to COVID-19 containment and to vaccine and drug efficacy. In this study, we analyzed more than 820,000 SARS-CoV-2 genomic sequences deposited up to March 26, 2021 and identified a novel T478K mutation located on the SARS-CoV-2 Spike protein.
› Verified 4 days ago
Dr. Kwok Kwong Wong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1235 Waverly Dr Se, Albany, OR 97322 Phone: 541-926-8668 | |
Whitney A. Buckley, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1086 7th Ave Sw, Albany, OR 97321 Phone: 541-768-5185 | |
Dr. Jennifer Garrison, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1333 Clay St Se, Albany, OR 97322 Phone: 541-924-9598 Fax: 541-967-8346 | |
Ms. Paula Marie Kwong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3031 Killdeer Ave Se, Albany, OR 97322 Phone: 541-918-7042 Fax: 541-918-7061 | |
Logan Whinery, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2255 14th Ave Se, Albany, OR 97322 Phone: 541-791-9566 | |
Ms. Michele Mahealani Wofford, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1990 14th Ave Se, Albany, OR 97322 Phone: 541-812-2386 Fax: 541-812-2388 |